NRx Pharmaceuticals (NRXP)
(Delayed Data from NSDQ)
$3.54 USD
+0.40 (12.74%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.75 +0.21 (5.93%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/21/24 |
---|---|
Current Quarter | NA |
EPS Last Quarter | -0.50 |
Last EPS Surprise | 28.57% |
ABR | 1.50 |
Earnings ESP
|
NA |
---|---|
Current Year | -4.00 |
Next Year | NA |
EPS (TTM) | -3.70 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | -4.00 | NA |
# of Estimates | NA | NA | 1 | NA |
Most Recent Consensus | NA | NA | -4.00 | NA |
High Estimate | NA | NA | -4.00 | NA |
Low Estimate | NA | NA | -4.00 | NA |
Year ago EPS | -1.30 | -1.20 | -3.70 | -4.00 |
Year over Year Growth Est. | NA | NA | -8.11% | NA |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | NA | NA | 0 | NA |
Up Last 30 Days | NA | NA | 0 | NA |
Up Last 60 Days | NA | NA | 0 | NA |
Down Last 7 Days | NA | NA | 0 | NA |
Down Last 30 Days | NA | NA | 0 | NA |
Down Last 60 Days | NA | NA | 0 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | NA | NA | -4.00 | NA |
7 Days Ago | NA | NA | -4.00 | NA |
30 Days Ago | -0.20 | -0.10 | -2.30 | -0.50 |
60 Days Ago | NA | NA | -2.50 | -0.80 |
90 Days Ago | NA | NA | -2.50 | -0.80 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | NA | NA | -4.00 | NA |
Zacks Consensus Estimate | NA | NA | -4.00 | NA |
Earnings ESP | NA | NA | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.50 | -0.70 | -1.20 | -1.30 | NA |
Estimate | -0.70 | -1.10 | -1.40 | -1.50 | NA |
Difference | 0.20 | 0.40 | 0.20 | 0.20 | 0.25 |
Surprise | 28.57% | 36.36% | 14.29% | 13.33% | 23.14% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more